Loxo Oncology Inc
(NASDAQ : LOXO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.46%179.181.2%$610.69m
CELGCelgene Corporation
1.20%77.531.2%$572.07m
GILDGilead Sciences, Inc.
0.35%68.070.9%$552.90m
BIIBBiogen Inc.
1.40%283.611.2%$527.93m
REGNRegeneron Pharmaceuticals, Inc.
0.05%294.842.6%$308.71m
ILMNIllumina, Inc.
0.13%271.163.5%$235.67m
VRTXVertex Pharmaceuticals Incorporated
-0.06%156.191.9%$230.29m
ALXNAlexion Pharmaceuticals, Inc.
-0.92%117.922.0%$222.86m
AAgilent Technologies, Inc.
-0.49%64.521.5%$209.71m
NKTRNektar Therapeutics
0.04%81.986.0%$198.38m
INCYIncyte Corporation
0.23%66.712.5%$177.04m
SRPTSarepta Therapeutics, Inc.
-0.88%88.4416.6%$123.92m
BMRNBioMarin Pharmaceutical Inc.
1.99%89.364.4%$119.68m
EXASExact Sciences Corporation
-3.30%51.2425.5%$112.24m
BLUEBluebird Bio, Inc.
1.62%188.6515.7%$96.25m

Company Profile

Loxo Oncology, Inc. is a biopharmaceutical company, which develops small molecule therapeutics for the treatment of cancer. Its pipeline focuses on cancers that are uniquely dependent on single gene abnormalities, such that a single drug has the potential to treat the cancer with dramatic effect. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT.